Status:
RECRUITING
Investigating the Functional Characteristics During Wakefulness and Sleep Based on SEEG
Lead Sponsor:
Xuanwu Hospital, Beijing
Conditions:
Refractory Epilepsy
Sleep
Eligibility:
All Genders
14-65 years
Phase:
NA
Brief Summary
This study aims to collect electrophysiological and clinical data from patients aged 14-65 with drug-resistant epilepsy who underwent SEEG. The collected data will be analyzed to investigate the funct...
Detailed Description
Sleep serves as a fundamental physiological state whose disruption has profound implications for neurological health. The daily alternation between sleep and wakefulness reflects an intrinsic circadia...
Eligibility Criteria
Inclusion
- Drug-resistant focal epilepsy
- Justified SEEG exploration in the context of presurgical assessment of epilepsy
- Subjects will be a part of the epilepsy-monitoring unit for long-term SEEG recordings and analysis
- Written non-opposition to study participation
Exclusion
- Pregnant women (Contraindication to SEEG exploration)
- Subjects that experience surgical complications during the implant procedure will be excluded from the study
Key Trial Info
Start Date :
July 8 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 8 2027
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06524479
Start Date
July 8 2024
End Date
October 8 2027
Last Update
June 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Beijing
Beijing, Beijing Municipality, China, 100000